ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

December 7, 2021
Open Access

Ropinirole hydrochloride for amyotrophic lateral sclerosis: A single-center, randomized feasibility, double-blind, placebo-controlled trial

MedRxiv : the Preprint Server for Health Sciences
Satoru MorimotoHideyuki Okano
December 7, 2021

Microglial TREM2 in amyotrophic lateral sclerosis.

Developmental Neurobiology
Manling XieLong-Jun Wu
December 6, 2021

Amyotrophic lateral sclerosis associated with a pathological expansion in the ATXN7 gene.

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
Florent CluseAntoine Pegat
December 6, 2021
Open Access

Methylation and Expression of Mutant FUS in Motor Neurons Differentiated From Induced Pluripotent Stem Cells From ALS Patients.

Frontiers in Cell and Developmental Biology
T HartungS Petri
December 6, 2021
Open Access

Rare CYLD Variants in Chinese Patients With Amyotrophic Lateral Sclerosis.

Frontiers in Genetics
Xiaojing GuHuifang Shang
December 6, 2021

Neurofilament markers in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.

Journal of Cellular and Molecular Medicine
Jiaying ShiWei Zhang
December 3, 2021
Open Access

ALS patients with concurrent neuroinflammatory disorders; a nationwide clinical records study.

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
Elisa LonginettiFang Fang
December 3, 2021

Validation of the DYALS (dysphagia in amyotrophic lateral sclerosis) questionnaire for the evaluation of dysphagia in ALS patients.

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Luca DiamantiDYALS Study Group
November 28, 2021

Nutrient Effects on Motor Neurons and the Risk of Amyotrophic Lateral Sclerosis.

Polina S GoncharovaNatalia A Shnayder
November 28, 2021
Open Access

Nearly 30 Years of Animal Models to Study Amyotrophic Lateral Sclerosis: A Historical Overview and Future Perspectives.

International Journal of Molecular Sciences
Tiziana BonifacinoMarco Milanese
November 28, 2021
Open Access

Epigenetic Small Molecules Rescue Nucleocytoplasmic Transport and DNA Damage Phenotypes in C9ORF72 ALS/FTD.

Brain Sciences
Melina RamicZane Zeier
November 27, 2021

Reversible sub-acute motor neuron syndrome after mushroom intoxication masquerading as amyotrophic lateral sclerosis.

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
Emmeline LagrangeWilliam Camu
November 27, 2021

A Brazilian multicentre study on the clinical and epidemiological profiles of 1116 patients with amyotrophic lateral sclerosis and its phenotypic variants.

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
Christian Marques CoutoOsvaldo J M Nascimento
November 25, 2021

Laryngospasm in Amyotrophic Lateral Sclerosis.

Muscle & Nerve
Ryan D GotesmanAri Breiner
November 24, 2021
Open Access

Astrocytic expression of ALS-causative mutant FUS leads to TNFa-dependent neurodegeneration in vivo

BioRxiv : the Preprint Server for Biology
B. K. JensenPiera Pasinelli

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

Alpha-Synuclein Aggregation

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

© 2021 Meta ULC. All rights reserved